Nucleus Network is Australia’s leading Phase I unit for the conduct of early phase clinical trials. We have an 80-bed EMA and FDA-inspected clinical trial unit, and more than 150 staff with strong industry background and expertise. Our reputation is based on experience of over 500 studies and expertise in First-in-Human, oncology and complex early phase studies. Nucleus conducts all studies to ICH-GCP guidelines. Approximately 90% of our clients are from overseas including US, European and Asian companies who recognize the value of performing studies in Australia with Nucleus to globally recognized standards of High Quality, Speed and Cost Effectiveness.